Verve Therapeutics (VV) revenue predicted to grow 99% in 2024, fall 42% in 2025, resulting in a 7% annualized growth rate over 2024-2025.
"Verve Therapeutics ticker VV is expected to grow Revenue by a stellar 99% this year but then to see it fall by 42% next year for an annualized rate of just 7% over the period"